↓ Skip to main content

Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer

Overview of attention for article published in Breast Cancer Research and Treatment, May 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

policy
1 policy source
twitter
1 X user
patent
8 patents

Citations

dimensions_citation
482 Dimensions

Readers on

mendeley
350 Mendeley
Title
Expression of programmed death ligand 1 (PD-L1) is associated with poor prognosis in human breast cancer
Published in
Breast Cancer Research and Treatment, May 2014
DOI 10.1007/s10549-014-2988-5
Pubmed ID
Authors

S. Muenst, A. R. Schaerli, F. Gao, S. Däster, E. Trella, R. A. Droeser, M. G. Muraro, P. Zajac, R. Zanetti, W. E. Gillanders, W. P. Weber, S. D. Soysal

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 350 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 <1%
Spain 1 <1%
Chile 1 <1%
Unknown 347 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 48 14%
Researcher 44 13%
Student > Ph. D. Student 43 12%
Student > Bachelor 30 9%
Student > Doctoral Student 29 8%
Other 63 18%
Unknown 93 27%
Readers by discipline Count As %
Medicine and Dentistry 114 33%
Biochemistry, Genetics and Molecular Biology 62 18%
Agricultural and Biological Sciences 27 8%
Immunology and Microbiology 22 6%
Nursing and Health Professions 4 1%
Other 16 5%
Unknown 105 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 May 2022.
All research outputs
#3,118,499
of 22,803,211 outputs
Outputs from Breast Cancer Research and Treatment
#508
of 4,655 outputs
Outputs of similar age
#32,414
of 226,453 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#10
of 60 outputs
Altmetric has tracked 22,803,211 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,655 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,453 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 60 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 83% of its contemporaries.